DonnaMildvanMD
Infectious Disease • New York, NYHIV/AIDS Medicine
Mount Sinai Beth Israel; Clinical Professor of Medicine, Icahn School of Medicine at Mount Sinai
Dr. Mildvan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
350 E 17th St
New York, NY 10003Phone+1 212-420-4005
Summary
- Dr. Donna Mildvan is an infectious disease specialist in New York, NY. She received her medical degree from Johns Hopkins University School of Medicine. She consults in hiv/aids medicine and infectious diseases and is experienced in hepatitis c, vaccines, and anti-hiv agents.
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Infectious Disease, 1970 - 1972- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1968 - 1970
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalInternship, Internal Medicine, 1967 - 1968
Johns Hopkins University School of MedicineClass of 1967
Certifications & Licensure
NY State Medical License 1969 - 2025
MD State Medical License 1970 - 1997
CA State Medical License 1972 - 1990- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Infectious Disease Specialist US News World Report Doctors
- America's Top Doctors Castle Connolly
- Top Doctors New York Metro Area Castle Connolly
- Join now to see all
Clinical Trials
- A Study to Compare Anti-HIV Drugs Given Twice a Day or Once a Day, With or Without Direct Observation
- Study of Once Daily Elvucitabine Versus Lamivudine in Participants With a Documented M184V Mutation Start of enrollment: 2006 Mar 31
- Open-Label, 48-Week Extension Study of Elvucitabine in Combination With Background Antiretroviral Therapy (ART) for Participants Who Have Completed Study ACH443-014A Start of enrollment: 2006 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 93 citationsTreatment of Community-Acquired Pneumonia in Immunocompromised Adults: A Consensus Statement Regarding Initial Strategies.Julio Ramirez, Daniel M. Musher, Scott E. Evans, Charles S. Dela Cruz, Kristina Crothers
Chest. 2020-11-01 - 22 citationsClinical features and outcomes of HIV-related cytomegalovirus pneumonia.Nadim Salomon, Tessa Gomez, David C. Perlman, Lisa Laya, Corey Eber
AIDS. 1997-03-01 - 70 citationsA randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy.Rajesh T. Gandhi, David O'Neill, Ronald J. Bosch, Ellen S. Chan, R. Pat Bucy
Vaccine. 2009-10-09
Press Mentions
Differences in Immune Response May Explain Why HIV-1 Disease Progresses Faster in Women Than in Men with Same Viral LoadJuly 13th, 2009
Grant Support
- Adult Therapeutic Clinical Trials Program In AIDSNational Institute Of Allergy And Infectious Diseases2000–2008
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
